Literature DB >> 2591464

Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.

A Marzo1, E Arrigoni Martelli, R Urso, M Rocchetti, V Rizza, J G Kelly.   

Abstract

The pharmacokinetics of acetyl-L-carnitine hydrochloride were investigated in 6 healthy volunteers of both sexes after i.v. injection of 500 mg of the drug, expressed as inner salt. Plasma concentrations and urinary excretion of acetyl-L-carnitine (A), L-carnitine (B) and total acid soluble L-carnitine fraction were evaluated over a period lasting from 24 h before to 48 h after the administration. Plasma concentrations of A increased quickly after administration and then declined reaching base values within 12 h. Conversely, plasma concentrations of B rose more slowly, reaching a peak in 30-60 min, and then declined to base values within 24 h. Most of the injected dose of acetyl-L-carnitine was recovered in the urine during the first 24 h after administration as B and A. Mean renal clearance of both A and B during the first 12 h after injection was higher than the base values, suggesting the presence of a saturable tubular reabsorption process which may counterbalance major changes occurring in plasma concentrations of L-carnitine pattern.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591464     DOI: 10.1007/bf00609426

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  CARNITINE ACETYLTRANSFERASE. II. INHIBIITON BY CARNITINE ANALOGUES AND BY SULFHYDRYL REAGENTS.

Authors:  I B FRITZ; S K SCHULTZ
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

2.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

Review 3.  Metabolite transport in mitochondria.

Authors:  K F LaNoue; A C Schoolwerth
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

4.  Carnitine synthesis in rat tissue slices.

Authors:  H T Haigler; H P Broquist
Journal:  Biochem Biophys Res Commun       Date:  1974-02-04       Impact factor: 3.575

5.  A method for the determination of carnitine in the picomole range.

Authors:  G Cederblad; S Lindstedt
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

6.  Biosynthesis of carnitine and 4-N-trimethylaminobutyrate from lysine.

Authors:  R A Cox; C L Hoppel
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

7.  Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport.

Authors:  C J Rebouche; A G Engel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Characterization of carnitine acylcarnitine translocase system of heart mitochondria.

Authors:  S V Pande; R Parvin
Journal:  J Biol Chem       Date:  1976-11-10       Impact factor: 5.157

9.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

10.  Kinetic compartmental analysis of carnitine metabolism in the dog.

Authors:  C J Rebouche; A G Engel
Journal:  Arch Biochem Biophys       Date:  1983-01       Impact factor: 4.013

View more
  10 in total

Review 1.  Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Authors:  Mike Youle
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid.

Authors:  Noboru Okamura; Shuichi Ohnishi; Hiroyuki Shimaoka; Ryo Norikura; Hiroshi Hasegawa
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 3.  Some pharmacokinetic considerations about homeostatic equilibrium of endogenous substances.

Authors:  A Marzo; A Rescigno; E Arrigoni Martelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

Review 4.  Pharmacokinetics of endogenous substances: some problems and some solutions.

Authors:  A Marzo; A Rescigno
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

5.  Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.

Authors:  L Parnetti; A Gaiti; P Mecocci; D Cadini; U Senin
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.

Authors:  J G Kelly; S Hunt; G D Doyle; M S Laher; M Carmody; A Marzo; E Arrigoni Martelli
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of drugs for Alzheimer's disease.

Authors:  L Parnetti
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

Review 8.  Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?

Authors:  Mariana G Rosca; Hélène Lemieux; Charles L Hoppel
Journal:  Adv Drug Deliv Rev       Date:  2009-08-29       Impact factor: 15.470

Review 9.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

10.  Septic Shock Nonsurvivors Have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.

Authors:  Michael A Puskarich; Charles R Evans; Alla Karnovsky; Arun K Das; Alan E Jones; Kathleen A Stringer
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.